Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 HKD | 0.00% | 0.00% | -9.78% |
04-30 | LH Group Limited Announces Board and Committee Changes | CI |
04-29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
Sales 2022 | 1.07B 137M 10.88B | Sales 2023 | 1.28B 164M 13.05B | Capitalization | 736M 94.22M 7.5B |
---|---|---|---|---|---|
Net income 2022 | 77M 9.86M 785M | Net income 2023 | 88M 11.27M 897M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 118M 15.14M 1.21B | Net Debt 2023 | 2.46M 315K 25.09M | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
8.36
x | Employees | 1,667 |
Yield 2022 |
7.26% | Yield 2023 |
9.58% | Free-Float | 25% |
3 months | -7.78% | ||
6 months | -17.82% | ||
Current year | -9.78% |
Managers | Title | Age | Since |
---|---|---|---|
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 19/06/17 |
Dong John Yang
DFI | Director of Finance/CFO | 49 | 10/04/23 |
Hiu Yi Chan
ADM | Chief Administrative Officer | 38 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wai Man Hung
BRD | Director/Board Member | 55 | 29/05/18 |
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 19/06/17 |
Sau Chee Ko
BRD | Director/Board Member | 58 | 19/06/17 |
Date | Price | Change | Volume |
---|---|---|---|
13/05/24 | 0.83 | 0.00% | 456 000 |
10/05/24 | 0.83 | 0.00% | 962,000 |
09/05/24 | 0.83 | +1.22% | 846,000 |
08/05/24 | 0.82 | 0.00% | 46,000 |
07/05/24 | 0.82 | -1.20% | 382,000 |
Delayed Quote Hong Kong S.E., May 13, 2024 at 09:08 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.78% | 84.98M | |
+35.02% | 11.17B | |
+18.43% | 8.76B | |
+40.46% | 2.62B | |
+6.28% | 2.25B | |
+11.25% | 1.92B | |
+12.80% | 1.76B | |
-0.18% | 1.46B | |
-17.15% | 945M | |
-3.30% | 789M |
- Stock Market
- Equities
- 1978 Stock